Literature DB >> 16715282

Trace analysis and occurrence of anhydroerythromycin and tylosin in influent and effluent wastewater by liquid chromatography combined with electrospray tandem mass spectrometry.

Shinwoo Yang1, Jongmun Cha, Kenneth Carlson.   

Abstract

Two wastewater treatment plants (WWTPs) of northern Colorado were monitored for anhydroerythromycin and tylosin. An analytical method has been developed and validated for the trace determination and confirmation of these compounds in the raw influent and final effluent water matrices. This method was used to evaluate the occurrence and fate of these compounds in WWTPs. The method uses solid-phase extraction and liquid chromatography-tandem mass spectrometry with positive electrospray ionization. Detection and quantification was performed using selected reaction monitoring, and a method detection limit of between 0.01 and 0.06 microg/L was obtained. Unequivocal confirmation analysis of analyte identity according to the criteria (based on the use of identification points) of the 2002/657/EC European Commission Decision was possible with satisfactory results. Average recoveries for the two compounds ranged from 89.2+/-9.7% for raw influent to 93.7+/-6.9% for effluent wastewaters. The within-run precision of the assay was found to be always less than 14.1% for the two analytes. The overall precision was always less than 13.7%. The relative uncertainty of the present assay was also evaluated and the combined relative uncertainty ranged from 6.4 to 15.5% over three days of the validation study. These compounds were partially removed in the WWTPs with a removal efficiency of >50%. The measured concentrations in raw influents and effluents ranged from 0.09-0.35 and 0.04-0.12 microg/L for anhydroerythromycin to 0.06-0.18 and ND-0.06 microg/L for tylosin, respectively. The results indicate that WWTP effluents are relevant point sources for residues of these compounds in the aquatic environment. These occurrence results were compared with those in WWTP wastewaters of other countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715282     DOI: 10.1007/s00216-006-0416-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

1.  Formation of new disinfection by-products of priority substances (Directive 2013/39/UE and Watch List) in drinking water treatment.

Authors:  Adrià Rubirola; Mª Rosa Boleda; Mª Teresa Galceran; Encarnación Moyano
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-31       Impact factor: 4.223

2.  Influence of trace erythromycin and eryhthromycin-H2O on carbon and nutrients removal and on resistance selection in sequencing batch reactors (SBRs).

Authors:  Caian Fan; Patrick K H Lee; Wun Jern Ng; Lisa Alvarez-Cohen; Eoin L Brodie; Gary L Andersen; Jianzhong He
Journal:  Appl Microbiol Biotechnol       Date:  2009-11       Impact factor: 4.813

3.  An optimized SPE-LC-MS/MS method for antibiotics residue analysis in ground, surface and treated water samples by response surface methodology- central composite design.

Authors:  Roya Mirzaei; Masoud Yunesian; Simin Nasseri; Mitra Gholami; Esfandiyar Jalilzadeh; Shahram Shoeibi; Hooshang Shafieyan Bidshahi; Alireza Mesdaghinia
Journal:  J Environ Health Sci Eng       Date:  2017-10-17

4.  Determination of Ten Macrolide Drugs in Environmental Water Using Molecularly Imprinted Solid-Phase Extraction Coupled with Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Xuqin Song; Tong Zhou; Jiufeng Li; Meiyu Zhang; Jingmeng Xie; Limin He
Journal:  Molecules       Date:  2018-05-14       Impact factor: 4.411

5.  Multiclass analysis of antimicrobial drugs in shrimp muscle by ultra high performance liquid chromatography-tandem mass spectrometry.

Authors:  Saksit Susakate; Saranya Poapolathep; Chanat Chokejaroenrat; Phanwimol Tanhan; Jana Hajslova; Mario Giorgi; Kanista Saimek; Zhaowei Zhang; Amnart Poapolathep
Journal:  J Food Drug Anal       Date:  2018-07-03       Impact factor: 6.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.